CIK: 1283303 - Address: C/o Travere Therapeutics, Inc., 3611 Valley Centre Dr., Suite 300, San Diego, CA 92130
10 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y

2/2/24 16:05
2/1/24
TVTXTravere Therapeutics, Inc.CAHealthDrugPharmaceutical PreparationsReed Elizabeth ECAOSVP,GC,CS.d-418.710-5-676D
1/25/24 16:10
1/23/24
TVTXTravere Therapeutics, Inc.CAHealthDrugPharmaceutical PreparationsReed Elizabeth ECAOSVP,GC,CS-188.960-2-456D
9/5/23 20:12
9/5/23
TVTXTravere Therapeutics, Inc.CAHealthDrugPharmaceutical PreparationsReed Elizabeth ECAOSVP,GC,CS-2714.710-2-358D
5/12/23 16:11
5/10/23
TVTXTravere Therapeutics, Inc.CAHealthDrugPharmaceutical PreparationsReed Elizabeth ECAOSVP,GC,CS-1416.590-1-157D
2/2/23 19:11
2/1/23
TVTXTravere Therapeutics, Inc.CAHealthDrugPharmaceutical PreparationsReed Elizabeth ECAOSVP,GC,CS.d-5822.250-3-457D
1/26/23 16:05
1/24/23
TVTXTravere Therapeutics, Inc.CAHealthDrugPharmaceutical PreparationsReed Elizabeth ECAOSVP,GC,CS-4421.500-2-540D
5/12/22 20:47
5/10/22
TVTXTravere Therapeutics, Inc.CAHealthDrugPharmaceutical PreparationsReed Elizabeth ECAOSVP,GC,CS.m-4221.510-2-442D
2/2/22 16:20
1/31/22
TVTXTravere Therapeutics, Inc.CAHealthDrugPharmaceutical PreparationsReed Elizabeth ECAOSVP,GC,CS.d-3727.400-1-344D
1/26/22 16:35
1/24/22
TVTXTravere Therapeutics, Inc.CAHealthDrugPharmaceutical PreparationsReed Elizabeth ECAOSVP,GC,CS-5624.980-2-635D
1/12/22 16:07
1/11/22
TVTXTravere Therapeutics, Inc.CAHealthDrugPharmaceutical PreparationsReed Elizabeth ECAOSVP,GC,CS-13727.400-5-1238D

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact